NRX Pharmaceuticals, Inc.

Q4 2024 13F Holders

Symbol
NRXP
CUSIP
629444209
Type
Equity
Class
COM NEW
Num filings
28
Total reported value, excl. options
$2.31 M
Manager Report Date Value ($000) Shares Option Type